# Minimizing Narcotic Analgesics After Endocrine Surgery

> **NCT03469310** · PHASE4 · COMPLETED · sponsor: **Minerva A Romero Arenas** · enrollment: 126 (actual)

## Conditions studied

- Thyroid Cancer
- Thyroid Nodule
- Thyroid Neoplasms
- Thyroid Goitre
- Thyroid Diseases
- Parathyroid Diseases
- Parathyroid Adenoma
- Parathyroid Hyperplasia

## Interventions

- **DRUG:** Acetaminophen 500Mg Cap
- **DRUG:** Tylenol #3 Oral Tablet
- **DRUG:** Tramadol

## Key facts

- **NCT ID:** NCT03469310
- **Lead sponsor:** Minerva A Romero Arenas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-09
- **Primary completion:** 2019-12-21
- **Final completion:** 2020-10-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469310, "Minimizing Narcotic Analgesics After Endocrine Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03469310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*